98 related articles for article (PubMed ID: 29406927)
1. Endoscopic screening for hereditary diffuse gastric cancer: one size does not fit all.
de Almeida Artifon EL; Marinho FRT
Gastrointest Endosc; 2018 Feb; 87(2):405-407. PubMed ID: 29406927
[No Abstract] [Full Text] [Related]
2. [Preventive resection of hereditary diffuse gastric cancer].
Hoogerbrugge N; Ligtenberg MJ; Nagengast FM; Bonenkamp JJ; van Krieken JH
Ned Tijdschr Geneeskd; 2006 Nov; 150(44):2417-20. PubMed ID: 17131699
[TBL] [Abstract][Full Text] [Related]
3. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
[TBL] [Abstract][Full Text] [Related]
4. Hereditary diffuse gastric cancer - pathophysiology and clinical management.
Pinheiro H; Oliveira C; Seruca R; Carneiro F
Best Pract Res Clin Gastroenterol; 2014 Dec; 28(6):1055-68. PubMed ID: 25439071
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria.
van der Post RS; van Dieren J; Grelack A; Hoogerbrugge N; van der Kolk LE; Snaebjornsson P; Lansdorp-Vogelaar I; van Krieken JH; Bisseling TM; Cats A
Gastrointest Endosc; 2018 Feb; 87(2):397-404.e2. PubMed ID: 28455161
[TBL] [Abstract][Full Text] [Related]
6. Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer.
Chen I; Mathews-Greiner L; Li D; Abisoye-Ogunniyan A; Ray S; Bian Y; Shukla V; Zhang X; Guha R; Thomas C; Gryder B; Zacharia A; Beane JD; Ravichandran S; Ferrer M; Rudloff U
J Transl Med; 2017 May; 15(1):92. PubMed ID: 28460635
[TBL] [Abstract][Full Text] [Related]
7. An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer.
Majewski IJ; Kluijt I; Cats A; Scerri TS; de Jong D; Kluin RJ; Hansford S; Hogervorst FB; Bosma AJ; Hofland I; Winter M; Huntsman D; Jonkers J; Bahlo M; Bernards R
J Pathol; 2013 Mar; 229(4):621-9. PubMed ID: 23208944
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer.
Carneiro F; Oliveira C; Suriano G; Seruca R
J Clin Pathol; 2008 Jan; 61(1):25-30. PubMed ID: 17513507
[TBL] [Abstract][Full Text] [Related]
9. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin mutations and hereditary gastric cancer: prevention by resection?
Fitzgerald RC; Caldas C
Dig Dis; 2002; 20(1):23-31. PubMed ID: 12145417
[TBL] [Abstract][Full Text] [Related]
11. Cate's Story: Hereditary Diffuse Gastric Cancer.
Rogers M
Clin J Oncol Nurs; 2016 Aug; 20(4):443-5. PubMed ID: 27441520
[TBL] [Abstract][Full Text] [Related]
12. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.
Oliveira C; Bordin MC; Grehan N; Huntsman D; Suriano G; Machado JC; Kiviluoto T; Aaltonen L; Jackson CE; Seruca R; Caldas C
Hum Mutat; 2002 May; 19(5):510-7. PubMed ID: 11968083
[TBL] [Abstract][Full Text] [Related]
13. Hereditary diffuse gastric cancer syndrome: improved performances of the 2015 testing criteria for the identification of probands with a CDH1 germline mutation.
Benusiglio PR; Colas C; Rouleau E; Uhrhammer N; Romero P; Remenieras A; Moretta J; Wang Q; De Pauw A; Buecher B; Stoppa-Lyonnet D; Mouret-Fourme E; Noguès C; Di Maria M; Tlemsani C; Warcoin M; Grandjouan S; Malka D; Caron O; Blayau M
J Med Genet; 2015 Aug; 52(8):563-5. PubMed ID: 26025002
[No Abstract] [Full Text] [Related]
14. The optimal endoscopic screening interval for detecting early gastric neoplasms.
Park CH; Kim EH; Chung H; Lee H; Park JC; Shin SK; Lee YC; An JY; Kim HI; Cheong JH; Hyung WJ; Noh SH; Kim CB; Lee SK
Gastrointest Endosc; 2014 Aug; 80(2):253-9. PubMed ID: 24613579
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer.
Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA
Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370
[TBL] [Abstract][Full Text] [Related]
16. Genetic testing by cancer site: stomach.
Chun N; Ford JM
Cancer J; 2012; 18(4):355-63. PubMed ID: 22846738
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin and hereditary diffuse gastric cancer.
Pedrazzani C; Corso G; Marrelli D; Roviello F
Surgery; 2007 Nov; 142(5):645-57. PubMed ID: 17981184
[No Abstract] [Full Text] [Related]
18. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening.
Carneiro F; Huntsman DG; Smyrk TC; Owen DA; Seruca R; Pharoah P; Caldas C; Sobrinho-Simões M
J Pathol; 2004 Jun; 203(2):681-7. PubMed ID: 15141383
[TBL] [Abstract][Full Text] [Related]
19. [Hereditary diffuse gastric cancer].
Puchmajerová A; Vasovčák P; Macháčková E; Foretová L; Křepelová A
Klin Onkol; 2012; 25 Suppl():S30-3. PubMed ID: 22920204
[TBL] [Abstract][Full Text] [Related]
20. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery.
Cisco RM; Ford JM; Norton JA
Cancer; 2008 Oct; 113(7 Suppl):1850-6. PubMed ID: 18798546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
